David James Carter, MD | |
1615 Hospital Pkwy, Suite 211, Bedford, TX 76022-5934 | |
(817) 545-6118 | |
(817) 684-8333 |
Full Name | David James Carter |
---|---|
Gender | Male |
Speciality | Thoracic Surgery |
Experience | 45 Years |
Location | 1615 Hospital Pkwy, Bedford, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164422440 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
St. Patrick Hospital | Missoula, MT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Providence Health And Services Mt | 6608786306 | 272 |
News Archive
AIDS Healthcare Foundation (AHF), the US' largest HIV/AIDS healthcare and prevention and education provider, which operates free AIDS treatment clinics in the US, Africa, Latin America/Caribbean and Asia, praised the Government of Thailand for its plan to break the patents on some lifesaving drugs, including one for an anti- retroviral drug used in the treatment of HIV/AIDS.
Writing in the Guardian's "Comment Is Free" blog, former British Prime Minister Tony Blair examines advances made in health and development across Africa since the Gleneagles G8 meeting in 2005, writing, "Today, the positive legacy of that summit is still being felt across Africa: aid was doubled and developing world debt dropped."
Researchers in the United States have successfully delivered a critical structural protein found in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to a human cell line and tracked its localization deep within the cells.
Mylan Laboratories has announced that the U.S. District Court for the District of Columbia has extended the deadlines pertaining to Mylan's request for a temporary restraining order in its lawsuit seeking to stop the U.S. Food and Drug Administration (FDA) from approving any other Amlodipine Besylate abbreviated new drug applications (ANDAs).
By comparing variations in protein expression in tumor samples from a single melanoma patient, researchers from the Johns Hopkins Bloomberg~Kimmel Institute and the Memorial Sloan-Kettering Cancer Center say their findings have the potential to reveal some of the mechanisms underlying response or resistance to immunotherapy drugs.
› Verified 9 days ago
Entity Name | Providence Health & Services Mt |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1144319138 PECOS PAC ID: 6608786306 Enrollment ID: O20031229000787 |
News Archive
AIDS Healthcare Foundation (AHF), the US' largest HIV/AIDS healthcare and prevention and education provider, which operates free AIDS treatment clinics in the US, Africa, Latin America/Caribbean and Asia, praised the Government of Thailand for its plan to break the patents on some lifesaving drugs, including one for an anti- retroviral drug used in the treatment of HIV/AIDS.
Writing in the Guardian's "Comment Is Free" blog, former British Prime Minister Tony Blair examines advances made in health and development across Africa since the Gleneagles G8 meeting in 2005, writing, "Today, the positive legacy of that summit is still being felt across Africa: aid was doubled and developing world debt dropped."
Researchers in the United States have successfully delivered a critical structural protein found in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to a human cell line and tracked its localization deep within the cells.
Mylan Laboratories has announced that the U.S. District Court for the District of Columbia has extended the deadlines pertaining to Mylan's request for a temporary restraining order in its lawsuit seeking to stop the U.S. Food and Drug Administration (FDA) from approving any other Amlodipine Besylate abbreviated new drug applications (ANDAs).
By comparing variations in protein expression in tumor samples from a single melanoma patient, researchers from the Johns Hopkins Bloomberg~Kimmel Institute and the Memorial Sloan-Kettering Cancer Center say their findings have the potential to reveal some of the mechanisms underlying response or resistance to immunotherapy drugs.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
David James Carter, MD 1615 Hospital Pkwy, Suite 211, Bedford, TX 76022-5934 Ph: (817) 545-6118 | David James Carter, MD 1615 Hospital Pkwy, Suite 211, Bedford, TX 76022-5934 Ph: (817) 545-6118 |
News Archive
AIDS Healthcare Foundation (AHF), the US' largest HIV/AIDS healthcare and prevention and education provider, which operates free AIDS treatment clinics in the US, Africa, Latin America/Caribbean and Asia, praised the Government of Thailand for its plan to break the patents on some lifesaving drugs, including one for an anti- retroviral drug used in the treatment of HIV/AIDS.
Writing in the Guardian's "Comment Is Free" blog, former British Prime Minister Tony Blair examines advances made in health and development across Africa since the Gleneagles G8 meeting in 2005, writing, "Today, the positive legacy of that summit is still being felt across Africa: aid was doubled and developing world debt dropped."
Researchers in the United States have successfully delivered a critical structural protein found in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to a human cell line and tracked its localization deep within the cells.
Mylan Laboratories has announced that the U.S. District Court for the District of Columbia has extended the deadlines pertaining to Mylan's request for a temporary restraining order in its lawsuit seeking to stop the U.S. Food and Drug Administration (FDA) from approving any other Amlodipine Besylate abbreviated new drug applications (ANDAs).
By comparing variations in protein expression in tumor samples from a single melanoma patient, researchers from the Johns Hopkins Bloomberg~Kimmel Institute and the Memorial Sloan-Kettering Cancer Center say their findings have the potential to reveal some of the mechanisms underlying response or resistance to immunotherapy drugs.
› Verified 9 days ago